P-glycoprotein (P-gp) function in T cells: Implications for organ transplantation

Clinical and Applied Immunology Reviews

Volumn 4, Issue 1, 2003, Pages 15-30

  Donnenberg, Vera S ^a   Burckart, Gilbert J ^a   Donnenberg, Albert D ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Cyclosporin A; Drug interactions; Graft rejection; MDR1; Organ transplantation; P glycoprotein; Physiological functions; Rhodamine 123; T cells

Indexed keywords

ABC TRANSPORTER; CORTICOSTEROID; CYCLOSPORIN; CYTOTOXIC AGENT; GLYCOPROTEIN P; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; TACROLIMUS; XENOBIOTIC AGENT;

APOPTOSIS; CELL LEVEL; CELL TRANSPORT; CONCENTRATION (PARAMETERS); DRUG RESISTANCE; DRUG RESPONSE; GENE OVEREXPRESSION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ORGAN TRANSPLANTATION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; TUMOR CELL;

EID: 0038648164     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(03)00004-7     Document Type: Review

References (83)

1. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance Cancer Chemother Pharmacol 40 Suppl 1997 S3-S8
2. Gottesman M.M. Pastan I. Ambudkar S.V. P-glycoprotein and multidrug resistance Curr Opin Genet Dev 6 1996 610-617
3. Dalton W. Sikic B. The multidrug resistance gene (MDR1) represents a potential target for reversing drug resistance in human malignancies J NIH Res 6 1994 54 6-8
4. Ueda K. Cornwell M.M. Gottesman M.M. Pastan I. Roninson I.B. Ling V. et al The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein Biochem Biophys Res Commun 141 3 1986 956-962
5. Gottesman M.M. Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter Annu Rev Biochem 62 1993 385-427
6. Ling V. Thompson L.H. Reduced permeability in CHO cells as a mechanism of resistance to colchicine J Cell Physiol 83 1 1974 103-116
7. Gottesman M.M. How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture Cancer Res 53 4 1993 747-754
8. Gottesman M.M. Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter Annu Rev Biochem 62 1993 385-427
9. Chan H.S. DeBoer G. Thorner P.S. Haddad G. Gallie B.L. Ling V. Multidrug resistance. Clinical opportunities in diagnosis and circumvention Hematolo Oncol Clin North Am 8 1994 383-410
10. Mansouri A. Henle K.J. Nagle W. Tumor drug-resistance: a challenge to therapeutics and biologists Am J Med Sci 307 1994 438-444
11. Lum B.L. Gosland M.P. MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors Hematol Oncol Clin North Am 9 1995 319-361
12. Borst P. Schinkel A.H. Smit J.J. Wagenaar E. Van Deemter L. Smith A.J. et al Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals Pharmacy and Therapeutics 60 1993 289-299
13. Chaudhary P.M. Roninson I.B. Expression and activity of P-glycoprotein-mediated multidrug efflux pump, in human hematopoietic stem cells Cell 66 1991 85-94
14. Chaudhary P.M. Mechetner E.B. Roninson I.B. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes Blood 80 1992 2735-2739
15. Licht T. Pastan I. Gottesman M. Herrmann F. P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells Ann Hematol 69 1994 159-171
16. Thiebaut F. Tsuruo T. Hamada H. Gottesman M.M. Pastan I. Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc Natl Acad Sci USA 84 1987 7735-7738
17. Lo A. Burckart G.J. P-glycoprotein and drug therapy in organ transplantation J Clin Pharmacol 39 1999 995-1005
18. Delaney M.P. Smythe E. Higgins R.M. Morris A.G. Constitutive and acquired resistance to calcineurin inhibitors in renal transplantation: role of P-glycoprotein-170 Transpl Int 13 4 2000 276-284
19. Ivy S.P. Olshefski R.S. Taylor B.J. Patel K.M. Reaman G.H. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study Blood 88 1 1996 309-318
20. Beck W.T. Grogan T.M. Willman C.L. Cordon-Cardo C. Parham D.M. Kuttesch J.F. et al Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations Cancer Res 56 13 1996 3010-3020
21. Webb M. Raphael C.L. Asbahr H. Erber W.N. Meyer B.F. The detection of rhodamine 123 efflux at low levels of drug resistance Br J Haematol 93 3 1996 650-655
22. De Moerloose B. Dhooge C. Philippe J. Discordance of P-glycoprotein expression and function in acute leukemia Adv Exp Med Biol 457 1999 107-118
23. Donnenberg V.S. Burckart G.J. Griffith B.P. Jain A.B. Zeevi A. Donnenberg A.D. P-glycoprotein (P-gp) is Upregulated in Peripheral T-Cell Subsets from Solid Organ Transplant Recipients J Clin Pharmacol 41 2001 1271-1279
24. Ruth A. Stein W.D. Rose E. Roninson I.B. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein Biochemistry 40 14 2001 4332-4339
25. Druley T.E. Stein W.D. Ruth A. Roninson I.B. P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation Biochemistry 40 14 2001 4323-4331
26. Druley T.E. Stein W.D. Roninson I.B. Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity Biochemistry 40 14 2001 4312-4322
27. Homolya L. Hollo M. Muller M. Mechetner E.B. Sarkadi B. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells Br J Cancer 73 7 1996 849-855
28. Darzynkiewicz Z. Staiano-Coico L. Melamed M.R. Increased mitochondrial uptake of rhodamine 123 during lymphocyte stimulation Proc Natl Acad Sci USA 78 4 1981 2383-2387
29. Drach J. Gsur A. Hamilton G. Zhao S. Angerler J. Fiegl M. et al Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes Blood 88 5 1996 1747-1754
30. Raghu G. Park S.W. Roninson I.B. Mechetner E.B. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes Exp Hematol 24 10 1996 1258-1264
31. Ford J.M. Modulators of multidrug resistance, preclinical studies Hematol Oncol Clinics North Am 9 2 1995 337-361
32. Klimecki W.T. Futscher B.W. Grogan T.M. Dalton W.S. P-glycoprotein expression and function in circulating blood cells from normal volunteers Blood 83 9 1994 2451-2458
33. Ikeda K. Oka M. Yamada Y. Soda H. Fukuda M. Kinoshita A. et al Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes Int J Cancer 82 4 1999 599-604
34. Morikawa A. Goto Y. Suzuki H. Hirohashi T. Sugiyama Y. Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2 Pharm Res 17 5 2000 546-552
35. Lamy T. Drenou B. Fardel O. Amiot L. Grulois I. Le Prise P.Y. et-al. Multidrug resistance analysis in lymphoproliferative disease of large granular lymphocytes Br J Haematol 100 3 1998 509-515
36. den Boer M.L. Pieters R. Kazemier K.M. Janka-Schaub G.E. Henze G. Veerman A.J. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia Leukemia 12 6 1998 912-920
37. Donnenberg V.S. Burckart G.J. Zeevi A. Griffith B.P. Iacono A. Donnenberg A.D. Verapamil inhibits or stimulates P-glycoprotein activity in human T-cells depending on the degree of constitutive P-glycoprotein activation [abstract] J Clin Pharmacol 40 2000 1063
38. Ludescher C. Eisterer W. Hilbe W. Hofmann J. Thaler J. Decreased potency of MDR-modulators under serum conditions determined by a functional assay Br J Haematol 91 3 1995 652-657
39. Pallis M. Turzanski J. Harrison G. Wheatley K. Langabeer S. Burnett A.K. et al Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia Br J Haematol 104 2 1999 307-312
40. De Moerloose B. Dhooge C. Laureys G. Benoit Y. Demarche M. Devalck C. et al Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors Cytometry 37 2 1999 125-132
41. Huet S. Marie J.P. Gualde N. Robert J. Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network Cytometry 34 6 1998 248-256
42. Vredenburg M.R. Ojima I. Veith J. Pera P. Kee K. Cabral F. et al Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance J Natl Cancer Inst 93 16 2001 1234-1245
43. Elbling L. Berger W. Weiss R.M. Printz D. Fritsch G. Micksche M. A novel bioassay for P-glycoprotein functionality using cytochalasin D Cytometry 31 3 1998 187-198
44. Picker L.J. Treer J.R. Ferguson-Darnell B. Collins P.A. Bergstresser P.R. Terstappen L.W. Control of lymphocyte recirculation in man: II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells J Immunol 150 3 1993 1122-1136
45. Johnstone R.W. Cretney E. Smyth M.J. P-glycoprotein protects leukemia cells against capase-dependent, but not caspase-independent, cell death Blood 93 1999 1075-1085
46. Gotzl M. Wallner J. Gsur A. Zochbauer S. Kovarik J. Balcke P. et al MDR1 gene expression in lymphocytes of patients with renal transplants Nephron 69 1995 277-280
47. Melk A. Daniel V. Weimer R. Mandelbaum A. Wiesel M. Staehler G. et al P-glycoprotein expression is not a useful predictor of acute or chronic kidney graft rejection Transpl Int 12 1 1999 10-17
48. Delaney M.P. Smythe E. Higgins R.M. Morris A.G. Constitutive and acquired resistance to calcineurin inhibitors in renal transplantation: role of P-glycoprotein-170 Transpl Int 13 4 2000 276-284
49. Kemnitz J. Uysal A. Haverich A. Heublein B. Cohnert T.R. Stangel W. et al Multidrug resistance in heart transplant patients: a preliminary communication on a possible mechanism of therapy-resistant rejection J Heart Lung Transplant 10 1991 201-210
50. Yousem S.A. Satori D. Sonmez-Alpan E. Multidrug resistance in lung allograft recipients: possible correlation with the development of acute and chronic rejection J Heart Lung Transplant 12 1993 20-26
51. Zheng H.X. Webber S. Zeevi A. Schuetz E. Zhang J. Lamba J. Bowman P. Burckart G.J. The MDRI polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients Human Immunology 63 9 2002 765-767
52. Sugawara I. Akiyama S. Scheper R.J. Itoyama S. Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP Cancer Lett 112 1 1997 23-31
53. Tsuji A. Sakata A. Tamai I. Tissue distribution of the multidrug-resistance gene product P-glycoprotein and its physiological function [abstract] Jpn J Clin Med 55 5 1997 1059-1063
54. Schinkel A.H. Pharmacological insights from P-glycoprotein knockout mice Int J Clin Pharmacol Ther 36 1 1998 9-13
55. Takikawa H. Yamazaki R. Sano N. Yamanaka M. Biliary excretion of estradiol-17 beta-glucuronide in the rat Hepatology 23 3 1996 607-613
56. Takahashi H. Kim R.B. Perry P.R. Wilkinson G.R. Characterization of the hepatic canalicular membrane transport of a model oligopeptide: ditekiren J Pharmacol Exp Ther 281 1 1997 297-303
57. Uematsu T. Yamaoka M. Matsuura T. Doto R. Hotomi H. Yamada A. et al P-glycoprotein expression in human major and minor salivary glands Arch Oral Biol 46 6 2001 521-527
58. Crivellato E. Travan L. Candussio L. Bartoli Klugmann F. Decorti G. Identification of P-glycoprotein at the membrane of mast cell secretory granules. An immunofluorescence and protein A-gold electron microscopical investigation Histochem J 29 3 1997 193-198
59. Elferink R.P. Groen A.K. The mechanism of biliary lipid secretion and its defects Gastroenterol Clin North Am 28 1 1999 59-74
60. Cufer T. Pfeifer M. Vrhovec I. Frangez R. Kosec M. Mrhar A. et al Decreased cortisol secretion by adrenal glands perfused with the P-glycoprotein inhibitor valspodar and mitotane or doxorubicin Anticancer Drugs 11 4 2000 303-309
61. Bello-Reuss E. Ernest S. Holland O.B. Hellmich M.R. Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells Am J Physiol Cell Physiol 278 6 2000 C1256-C1265
62. Kahan B.D. Chang J.Y. Sehgal S.N. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin Transplantation 52 1991 185-191
63. Frank M. Denton M. Alexander S. Khoury S. Sayegh M. Briscoe D. Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro J Immunol 166 4 2001 2451-2459
64. Eisenbraun M.D. Miller R.A. mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice J Immunol 163 5 1999 2621-2627
65. Borst P. Schinkel A.H. Genetic dissection of the function of mammalian P-glycoproteins Trends Genet 13 6 1997 217-222
66. Johnstone R.W. Tainton K.M. Ruefli A.A. Froelich C.J. Cerruti L. Jane S.M. et al P-glycoprotein does not protect cells against cytolysis induced by pore-forming proteins J Biol Chem 276 20 2001 16667-16673
67. Johnstone R.W. Ruefli A.A. Tainton K.M. Smyth M.J. A role for P-glycoprotein in regulating cell death Leuk Lymphoma 38 1-2 2000 1-11
68. Ruefli A.A. Smyth M.J. Johnstone R.W. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance Blood 95 7 2000 2378-2385
69. Ruth A.C. Roninson I.B. Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation Cancer Res 60 10 2000 2576-2578
70. Thevenod F. Friedmann J.M. Katsen A.D. Hauser I.A. Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis J Biol Chem 275 3 2000 1887-1896
71. Smyth M.J. Krasovskis E. Sutton V.R. Johnstone R.W. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis Proc Natl Acad Sci USA 95 12 1998 7024-7029
72. Lehne G. De Angelis P. den Boer M. Rugstad H.E. Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents Leukemia 13 5 1999 768-778
73. Lucci A. Han T.Y. Liu Y.Y. Giuliano A.E. Cabot M.C. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells Cancer 86 2 1999 300-311
74. Burek C. Roth J. Koch H.G. Harzer K. Los M. Schulze-Osthoff K. The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells Oncogene 20 45 2001 6493-6502
75. Andrieu-Abadie N. Gouaze V. Salvayre R. Levade T. Ceramide in apoptosis signaling: relationship with oxidative stress Free Radic Biol Med 31 6 2001 717-728
76. Ohanian J. Ohanian V. Sphingolipids in mammalian cell signalling Cell Mol Life Sci 58 14 2001 2053-2068
77. Pallis M. Russell N. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway Blood 95 9 2000 2897-2904
78. Bates S.E. Wilson W.H. Fojo A.T. Alvarez M. Zhan Z. Regis J. et al Clinical reversal of multidrug resistance Stem Cells 14 1 1996 56-63
79. Advani R. Saba H.I. Tallman M.S. Rowe J.M. Wiernik P.H. Ramek J. et al Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar) Blood 93 3 1999 787-795
80. Bertilsson P.M. Olsson P. Magnusson K.E. Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells J Pharm Sci 90 5 2001 638-646
81. Sukhai M. Yong A. Pak A. Piquette-Miller M. Decreased expression of P-glycoprotein in interleukin1beta and interleukin-6 treated rat hepatocytes Inflamm Res 50 7 2001 362-370
82. Liao J.S. Reiss W.G. Drug-cytokine interactions: focus on cyclosporine Pharmacotherapy 16 3 1996 401-408
83. Warren G.W. Poloyac S.M. Gary D.S. Mattson M.P. Blouin R.A. Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration J Pharmacol Exp Ther 288 3 1999 945-950